BACKGROUND: The current population of older Americans has accumulated substantial lifetime lead doses, which raises concern about the possibility of adverse cognitive outcomes. We evaluated whether cumulative lead dose from environmental exposures is associated with cognitive function and decline, and whether such effects are persistent, reversible, or progressive. METHODS: We used longitudinal linear modeling to evaluate associations of tibia lead concentration with cognitive function and decline in sociodemographically diverse, community-dwelling adults aged 50-70 years who were randomly selected from neighborhoods in Baltimore. Six summary measures of cognitive function were created from standard tests in the following domains: language, processing speed, eye-hand coordination, executive functioning, verbal memory and learning, and visual memory. RESULTS: The mean (SD) tibia lead level was 18.8 (11.6) microg/g. In models adjusted for demographic characteristics, socioeconomic status (SES), and race/ethnicity, higher tibia lead was associated with a progressive decline in eye-hand coordination. Tibia lead was associated with persistently impaired cognitive function in all 6 domains, although these associations weakened after increasing covariate control. In fully adjusted stratified analysis among white persons, persistent effects were apparent in eye-hand coordination, executive functioning, and verbal memory and learning. CONCLUSIONS: The study presents the strongest evidence to date of the effects of cumulative lead dose on adult cognitive function independent of SES. The study population was relatively young and the average total duration of follow-up short (<30 months); these findings may represent the lower bound of the impact of cumulative lead dose on cognitive function of older adults.
BACKGROUND: The current population of older Americans has accumulated substantial lifetime lead doses, which raises concern about the possibility of adverse cognitive outcomes. We evaluated whether cumulative lead dose from environmental exposures is associated with cognitive function and decline, and whether such effects are persistent, reversible, or progressive. METHODS: We used longitudinal linear modeling to evaluate associations of tibia lead concentration with cognitive function and decline in sociodemographically diverse, community-dwelling adults aged 50-70 years who were randomly selected from neighborhoods in Baltimore. Six summary measures of cognitive function were created from standard tests in the following domains: language, processing speed, eye-hand coordination, executive functioning, verbal memory and learning, and visual memory. RESULTS: The mean (SD) tibia lead level was 18.8 (11.6) microg/g. In models adjusted for demographic characteristics, socioeconomic status (SES), and race/ethnicity, higher tibia lead was associated with a progressive decline in eye-hand coordination. Tibia lead was associated with persistently impaired cognitive function in all 6 domains, although these associations weakened after increasing covariate control. In fully adjusted stratified analysis among white persons, persistent effects were apparent in eye-hand coordination, executive functioning, and verbal memory and learning. CONCLUSIONS: The study presents the strongest evidence to date of the effects of cumulative lead dose on adult cognitive function independent of SES. The study population was relatively young and the average total duration of follow-up short (<30 months); these findings may represent the lower bound of the impact of cumulative lead dose on cognitive function of older adults.
Authors: Marc G Weisskopf; Susan P Proctor; Robert O Wright; Joel Schwartz; Avron Spiro; David Sparrow; Huiling Nie; Howard Hu Journal: Epidemiology Date: 2007-01 Impact factor: 4.822
Authors: B S Schwartz; B K Lee; G S Lee; W F Stewart; S S Lee; K Y Hwang; K D Ahn; Y B Kim; K I Bolla; D Simon; P J Parsons; A C Todd Journal: Am J Epidemiol Date: 2001-03-01 Impact factor: 4.897
Authors: B S Schwartz; W F Stewart; K I Bolla; P D Simon; K Bandeen-Roche; P B Gordon; J M Links; A C Todd Journal: Neurology Date: 2000-10-24 Impact factor: 9.910
Authors: Gavin Turrell; John W Lynch; George A Kaplan; Susan A Everson; Eeva-Liisa Helkala; Jussi Kauhanen; Jukka T Salonen Journal: J Gerontol B Psychol Sci Soc Sci Date: 2002-01 Impact factor: 4.077
Authors: Brian K Lee; Thomas A Glass; Matthew J McAtee; Gary S Wand; Karen Bandeen-Roche; Karen I Bolla; Brian S Schwartz Journal: Arch Gen Psychiatry Date: 2007-07
Authors: Ki-Do Eum; Florence T Wang; Joel Schwartz; Craig P Hersh; Karl Kelsey; Robert O Wright; Avron Spiro; David Sparrow; Howard Hu; Marc G Weisskopf Journal: Neurotoxicology Date: 2013-08-16 Impact factor: 4.294
Authors: Zishaan Farooqui; Kelly M Bakulski; Melinda C Power; Marc G Weisskopf; David Sparrow; Avron Spiro; Pantel S Vokonas; Linda H Nie; Howard Hu; Sung Kyun Park Journal: Environ Res Date: 2016-10-19 Impact factor: 6.498
Authors: Jennifer Weuve; Daniel Z Press; Francine Grodstein; Robert O Wright; Howard Hu; Marc G Weisskopf Journal: Mov Disord Date: 2012-11-09 Impact factor: 10.338
Authors: Melinda C Power; Susan Korrick; Eric J Tchetgen Tchetgen; Linda H Nie; Francine Grodstein; Howard Hu; Jennifer Weuve; Joel Schwartz; Marc G Weisskopf Journal: Environ Res Date: 2014-01-29 Impact factor: 6.498
Authors: Rachel Grashow; Mark W Miller; Ann McKinney; Linda H Nie; David Sparrow; Howard Hu; Marc G Weisskopf Journal: Neurotoxicol Teratol Date: 2013-04-17 Impact factor: 3.763